The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...

Merck, which previously predicted 2024 sales between 20.7 billion ... continues to regain ground from a slump after the end ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

Merck was founded in 1668 and is the world’s oldest operating chemical and pharmaceutical company. Asuka Koda covers the Yale ...

Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ETCompany ParticipantsConstantin Fest - Head of Investor ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Merck's Q3 revenue rises, led by Keytruda's strong 17% YoY growth. Gardasil demand challenges in China impact sales, with ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Joseph Romanelli, president, Human Health International, and Dr. Marjorie Green, senior vice president and ...

German companies including Merck and ZEISS expressed strong confidence and high hopes for the Chinese market at the China ...

The price of ethereum, or 1 ETH, was $2,633.95 as of 8 a.m. ET. The crypto’s highest intraday price in the past year was ...

The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...